Amgen (NASDAQ:AMGN) reported quarterly earnings of $4.38 per share which beat the analyst consensus estimate of $4.06 by 7.88 percent. This is a 3.06 percent increase over earnings of $4.25 per share from the same period last year. The company reported quarterly sales of $6.50 billion which beat the analyst consensus estimate of $6.43 billion by 1.09 percent. This is a 4.74 percent increase over sales of $6.21 billion the same period last year.
Amgen Q2 Adj. EPS $4.38 Beats $4.06 Estimate, Sales $6.50B Beat $6.43B Estimate
Amgen (NASDAQ:AMGN) reported quarterly earnings of $4.38 per share which beat the analyst consensus estimate of $4.06 by 7.88 percent. This is a 3.06 percent increase over earnings of $4.25 per share from the same period